These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity. Lammering G; Hewit TH; Holmes M; Valerie K; Hawkins W; Lin PS; Mikkelsen RB; Schmidt-Ullrich RK Clin Cancer Res; 2004 Oct; 10(19):6732-43. PubMed ID: 15475464 [TBL] [Abstract][Full Text] [Related]
5. Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells. Reardon DB; Contessa JN; Mikkelsen RB; Valerie K; Amir C; Dent P; Schmidt-Ullrich RK Oncogene; 1999 Aug; 18(33):4756-66. PubMed ID: 10467423 [TBL] [Abstract][Full Text] [Related]
6. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation. Contessa JN; Abell A; Mikkelsen RB; Valerie K; Schmidt-Ullrich RK Breast Cancer Res Treat; 2006 Jan; 95(1):17-27. PubMed ID: 16267617 [TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells. Lammering G; Lin PS; Contessa JN; Hampton JL; Valerie K; Schmidt-Ullrich RK Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):775-84. PubMed ID: 11697324 [TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization. Lammering G; Hewit TH; Hawkins WT; Contessa JN; Reardon DB; Lin PS; Valerie K; Dent P; Mikkelsen RB; Schmidt-Ullrich RK J Natl Cancer Inst; 2001 Jun; 93(12):921-9. PubMed ID: 11416113 [TBL] [Abstract][Full Text] [Related]
9. Multiple mitogenic pathways in pancreatic cancer cells are blocked by a truncated epidermal growth factor receptor. Matsuda K; Idezawa T; You XJ; Kothari NH; Fan H; Korc M Cancer Res; 2002 Oct; 62(19):5611-7. PubMed ID: 12359775 [TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor in cultured human retinal pigment epithelial cells. Yan F; Hui YN; Li YJ; Guo CM; Meng H Ophthalmologica; 2007; 221(4):244-50. PubMed ID: 17579290 [TBL] [Abstract][Full Text] [Related]
11. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors. Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219 [TBL] [Abstract][Full Text] [Related]
12. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells. Ram TG; Hosick HL; Ethier SP J Cell Physiol; 2000 Jun; 183(3):301-13. PubMed ID: 10797304 [TBL] [Abstract][Full Text] [Related]
13. Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS. Toulany M; Dittmann K; Baumann M; Rodemann HP Radiother Oncol; 2005 Feb; 74(2):117-29. PubMed ID: 15734199 [TBL] [Abstract][Full Text] [Related]
14. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways. Tuck AB; Hota C; Wilson SM; Chambers AF Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946 [TBL] [Abstract][Full Text] [Related]
15. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis. Casanova ML; Larcher F; Casanova B; Murillas R; Fernández-Aceñero MJ; Villanueva C; Martínez-Palacio J; Ullrich A; Conti CJ; Jorcano JL Cancer Res; 2002 Jun; 62(12):3402-7. PubMed ID: 12067982 [TBL] [Abstract][Full Text] [Related]
16. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells. Johnson FM; Saigal B; Donato NJ J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238 [TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia. Maity A; Pore N; Lee J; Solomon D; O'Rourke DM Cancer Res; 2000 Oct; 60(20):5879-86. PubMed ID: 11059786 [TBL] [Abstract][Full Text] [Related]
18. Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFr) enhances the radiosensitization properties of anti-EGFr treatment in prostate cancer cells. Bonner JA; Buchsbaum DJ; Rogers BE; Grizzle WE; Trummell HQ; Curiel DT; Fiveash JB; Ove R; Raisch KP Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):950-8. PubMed ID: 14967455 [TBL] [Abstract][Full Text] [Related]
19. Radiation-induced autophosphorylation of epidermal growth factor receptor in human malignant mammary and squamous epithelial cells. Schmidt-Ullrich RK; Valerie K; Fogleman PB; Walters J Radiat Res; 1996 Jan; 145(1):81-5. PubMed ID: 8532841 [TBL] [Abstract][Full Text] [Related]
20. Selective downregulation of EGF receptor and downstream MAPK pathway in human cancer cell lines by active components partially purified from the seeds of Livistona chinensis R. Brown. Huang WC; Hsu RM; Chi LM; Leu YL; Chang YS; Yu JS Cancer Lett; 2007 Apr; 248(1):137-46. PubMed ID: 16919867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]